Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial toxin vaccines.

F Dorner, J L McDonel

    Vaccine
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    New vaccine development strategies, including attenuated organisms and toxin subunits, are emerging to combat infectious bacterial diseases. These advanced methods offer novel solutions to persistent health threats posed by bacterial toxins.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage.

    Cytotechnology·2008
    Same author

    Systematic evaluation of different approaches for minimizing hemodynamic changes during pneumoperitoneum.

    Surgical endoscopy·2006
    Same author

    Cloning, expression and functional characterization of the full-length murine ADAMTS13.

    Journal of thrombosis and haemostasis : JTH·2005
    Same author

    [Infections and diseases after travelling].

    Deutsche medizinische Wochenschrift (1946)·2002
    Same author

    Thrombin-mediated in vitro processing of pro-von Willebrand factor.

    Thrombosis and haemostasis·2002
    Same author

    Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection.

    Applied and environmental microbiology·2001
    Same journal

    Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

    Vaccine·2026
    Same journal

    Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

    Vaccine·2026
    Same journal

    Vaccination policies for healthcare personnel in Europe, 2026.

    Vaccine·2026
    Same journal

    A historical overview of the anti-vaccine movement and its public health implications.

    Vaccine·2026
    Same journal

    Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

    Vaccine·2026
    Same journal

    Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

    Vaccine·2026
    See all related articles

    Area of Science:

    • Microbiology
    • Immunology
    • Biotechnology

    Background:

    • Infectious diseases caused by bacterial toxins remain a significant global health concern.
    • Recent technological advancements have revitalized vaccine development research.
    • Traditional vaccine approaches are being augmented by modern biotechnological methods.

    Purpose of the Study:

    • To review novel vaccine development strategies against bacterial toxin-mediated diseases.
    • To discuss the application of genetic technologies and toxin subunit approaches in vaccine design.
    • To highlight advancements in combating bacterial pathogens.

    Main Methods:

    • Review of current literature on vaccine development.
    • Analysis of approaches using attenuated organisms (classical and genetic).

    Related Experiment Videos

  • Examination of strategies employing toxin subunits (genetically engineered, synthesized, or modified).

    • Main Results:

    • Vaccine development is increasingly utilizing genetic technologies for organism attenuation.
    • Toxin subunit vaccines are being developed through various protein engineering techniques.
    • These novel approaches show promise for addressing challenging bacterial infections.

    Conclusions:

    • Modern vaccine development leverages advanced techniques like genetic engineering and subunit technology.
    • These strategies offer new avenues for creating effective vaccines against bacterial toxins.
    • Continued innovation in vaccine development is crucial for public health.